Keyword: GlaxoSmithKline (GSK)

News

GSK Cancer Drug Combination Wins US Priority Review

18.09.2013 - A combination treatment from GlaxoSmithkline for melanoma, the deadliest form of skin cancer, has won priority review from U.S. regulators. The move means the Food and Drug...

News

Teva to Drop Depression Treatment after Trial Fails

02.09.2013 - Generic drug maker Teva Pharmaceutical Industries said it will stop the development of a depression treatment after a late-stage trial failed to show the drug was more effective...

News

Amgen Buys Onyx for $10.4 Billion

26.08.2013 - Amgen struck a deal to buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion on Sunday, as it moves to restock its product pipeline in response to declining sales of...

News

Briton Peter Humphrey Arrested Amid Chinese Pharmaceuticals Probe

23.08.2013 - A British risk consultant held in China since mid-July amid an investigation into the country's pharmaceutical industry has been arrested, the British Embassy in Beijing and his...

News

China to Launch Fresh Pharmaceutical Bribery Probe

15.08.2013 - China is intensifying its investigation into rampant bribery in the pharmaceutical and medical services sector with a fresh three-month probe slated to begin on Thursday, the...

News

China Investigates France's Sanofi for Alleged Bribery

12.08.2013 - China has started investigating French drugmaker Sanofi for allegedly bribing more than 500 Chinese doctors with about 1.7 million yuan ($277,600) of payments to raise sales, China...

News

Top Insulin Maker Novo Caught Up In China's Widening Drug Probes

09.08.2013 - Chinese authorities have visited a site operated by Danish drug maker Novo Nordisk, the world's biggest maker of insulin, in the latest sign of a widening investigation into...

News

GSK Plugs into Bioelectronics with $50 Million Venture Fund

09.08.2013 - GlaxoSmithKline raised its bet on using electrical signals in the body to target diseases on Thursday with the launch of a $50 million strategic venture capital fund. Britain's...